Related Experiment Video
Updated: Jun 10, 2025

10:31
Antigenic Liposomes for Generation of Disease-specific Antibodies
Published on: October 25, 2018
12.3K
Immune repertoire profiling in myasthenia gravis
Ting He1, Kangzhi Chen1, Qian Zhou1
1Department of Neurology, Xiangya Hospital, Central South University, Changsha, China.
Immunology and Cell Biology
|October 13, 2024
Summary
Myasthenia gravis (MG) involves immune cells producing autoantibodies. Immune repertoire sequencing helps understand MG
Area of Science:
- Immunology
- Neurology
- Genomics
Background:
- Myasthenia gravis (MG) is a common autoimmune neurological disorder causing muscle weakness.
- Autoantibodies produced by B cells, triggered by T-cell and B-cell interactions recognizing self-antigens, are key to MG.
- The immune repertoire, encompassing all T and B cells, offers insights into immune selectivity.
Purpose of the Study:
- To review the generation of autoreactive T-cell receptors (TCRs) and B-cell receptors (BCRs) in MG.
- To explore the applications of immune repertoire sequencing in MG pathogenesis, diagnostics, and therapeutics.
- To discuss the limitations and future directions of immune repertoire sequencing in MG research.
Main Methods:
- Review of existing literature on MG and immune repertoire sequencing.
- Analysis of studies utilizing TCR and BCR sequencing to track T and B cell clones.
- Examination of the role of self-antigen recognition in autoreactive receptor generation.
Main Results:
- Immune repertoire sequencing allows tracking of individual T and B cell clones in MG.
- This technique provides a deeper understanding of the immune basis of MG.
- Applications include identifying diagnostic/prognostic markers and guiding targeted therapies.
Conclusions:
- Immune repertoire sequencing is a powerful tool for understanding MG pathogenesis.
- It holds significant potential for developing novel diagnostic and therapeutic strategies for MG.
- Further research is needed to overcome current limitations and fully leverage this technology.
Related Concept Videos
Myasthenia Gravis: Diagnostic Tests
686
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
686
Myasthenia Gravis: Overview and Treatment
1.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.2K

